Cargando…

BSCI-14. tGLI1 is an actionable therapeutic target in breast cancer brain metastases

Breast cancer is the second leading cause of brain metastases in women; patients with breast cancer brain metastasis (BCBM) survive a median of 14.1 months following diagnosis. Cancer stem cells are thought to be one of the driving forces behind distant metastasis, treatment resistance, and late-sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doheny, Daniel, Manore, Sara, Wong, Grace, Zhu, Dongqin, Sirkisoon, Sherona, Rimkus, Tadas, Anguelov, Marlyn, Aguayo, Noah, Regua, Angelina, Cox, Anderson O’Brian, Furdui, Cristina, Thomas, Alexandra, Masters, Adrianna Henson, Strowd, Roy, Lo, Hui-Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351283/ http://dx.doi.org/10.1093/noajnl/vdab071.013

Ejemplares similares

54. tGLI1 IS AN ACTIONABLE THERAPEUTIC TARGET IN BREAST CANCER BRAIN METASTASES
por: Doheny, Daniel, et al.
Publicado: (2020)

BSCI-02. tGLI1 IS A NOVEL, ACTIONABLE TARGET FOR THE TREATMENT OF BREAST CANCER BRAIN METASTASES
por: Doheny, Daniel, et al.
Publicado: (2019)

BSCI-13. TUMOR-SPECIFIC tGLI1 TRANSCRIPTION FACTOR MEDIATES BREAST CANCER BRAIN METASTASIS VIA ACTIVATING METASTASIS-INITIATING CANCER STEM CELLS AND ASTROCYTES IN THE TUMOR MICROENVIRONMENT
por: Sirkisoon, Sherona, et al.
Publicado: (2019)

An FDA-Approved Antifungal, Ketoconazole, and Its Novel Derivative Suppress tGLI1-Mediated Breast Cancer Brain Metastasis by Inhibiting the DNA-Binding Activity of Brain Metastasis-Promoting Transcription Factor tGLI1
por: Doheny, Daniel, et al.
Publicado: (2022)

Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis
por: Doheny, Daniel, et al.
Publicado: (2020)

TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment
por: Sirkisoon, Sherona R., et al.
Publicado: (2019)

Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative and HER2-enriched breast cancers
por: Sirkisoon, Sherona R., et al.
Publicado: (2018)

The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis
por: Carpenter, Richard L., et al.
Publicado: (2015)

TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers
por: Regua, Angelina T., et al.
Publicado: (2021)

Hedgehog Signaling and Truncated GLI1 in Cancer
por: Doheny, Daniel, et al.
Publicado: (2020)

BSCI
por: Shannon Michael J
Publicado: (2004)

Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth
por: Carpenter, Richard L., et al.
Publicado: (2017)

Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
por: Rimkus, Tadas K., et al.
Publicado: (2016)

Upregulation of VEGF-A and CD24 Gene Expression by the tGLI1 Transcription Factor Contributes to the Aggressive Behavior of Breast Cancer Cells
por: Cao, Xinyu, et al.
Publicado: (2011)

Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer
por: Najjar, Mariana K., et al.
Publicado: (2022)

Efficacy of low-dose radiotherapy for refractory mycosis fungoides of the face
por: Masters, Adrianna Henson, et al.
Publicado: (2019)

CCNP BSCI quick reference sheets.
por: Stewart, Brent, et al.
Publicado: (2006)

CCNP BSCI portable command guide
por: Empson, Scott
Publicado: (2007)

CCNP BSCI official exam certification guide
por: Stewart, Brent, et al.
Publicado: (2007)

BSCI-05 REPURPOSING PROPOFOL FOR THE TREATMENT OF BRAIN METASTASES
por: Penning, Donald, et al.
Publicado: (2022)

BSCI-20. THERAPEUTIC TARGETING OF HLA-G IN BRAIN METASTASES
por: Singh, Sheila, et al.
Publicado: (2019)

Building scalable Cisco internetworks (BSCI): authorized self-study guide
por: Paquet, Catherine, et al.
Publicado: (2006)

BSCI-17. YOUNG AGE PROMOTES BREAST CANCER METASTASIS TO THE BRAIN
por: Wu, Alex, et al.
Publicado: (2019)

BSCI-07. BONE MARROW T-CELL SEQUESTRATION IN THE SETTING OF BRAIN METASTASES
por: Chongsathidkiet, Pakawat, et al.
Publicado: (2019)

BSCI-19. Therapeutic intervention of lung-, breast-, and melanoma-brain metastasis
por: Kieliszek, Agata, et al.
Publicado: (2021)

BSCI-01. Small RNAseq analysis of microRNAs in brain metastasis
por: Jancalek, Radim, et al.
Publicado: (2021)

BSCI-07 ACETYL-AMANTADINE AS A DIAGNOSTIC BIOMARKER IN PATIENTS WITH GLIOBLASTOMA
por: Mann, Anmol, et al.
Publicado: (2022)

BSCI-21 COX4I1 EXPRESSION IN BRAIN METASTASES
por: Saad, Mahak, et al.
Publicado: (2022)

BSCI-23. TISSUE FACTOR SIGNALING ENHANCES METASTATIC BRAIN CANCER MALIGNANCY
por: Unruh, Dusten, et al.
Publicado: (2019)

BSCI-27. MELATONIN REDUCES MALIGNANCY OF BREAST CANCER BRAIN METASTATIC CELLS
por: Gil, Beatriz Fernandez, et al.
Publicado: (2019)

BSCI-13. MTH1 expression is upregulated in brain metastases of malignant melanoma
por: Timmer, Marco
Publicado: (2021)

Iceberg Indicators for Animal Welfare in Rural Sheep Farms Using the Five Domains Model Approach
por: Hernandez, Rick Obrian, et al.
Publicado: (2020)

Field Trial of Factors Associated With the Presence of Dead and Non-ambulatory Pigs During Transport Across Three Colombian Slaughterhouses
por: Romero, Marlyn H., et al.
Publicado: (2022)

RET signaling pathway and RET inhibitors in human cancer
por: Regua, Angelina T., et al.
Publicado: (2022)

BSCI-03. T CELL EXHAUSTION SIGNATURES VARY BY TUMOR TYPE AND ARE INDEPENDENT OF INTRACRANIAL LOCATION
por: Woroniecka, Karolina, et al.
Publicado: (2019)

BSCI-12. COMPREHENSIVE GENOMIC ANALYSIS OF BRAIN METASTASES FROM MULTIPLE CANCER TYPES
por: Fukumura, Kazutaka, et al.
Publicado: (2019)

BSCI-25. THE ROLE OF THE IFNγ PATHWAY IN BREAST CANCER BRAIN METASTASIS FORMATION
por: Pedrosa, Route, et al.
Publicado: (2019)

BSCI-12. Inhibition of melanoma brain metastasis by targeting miR-146a
por: Wang, Jiwei, et al.
Publicado: (2021)

BSCI-16. Olfactory receptor 5B21 drives breast cancer metastasis
por: Li, Mao, et al.
Publicado: (2021)

BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy
por: Zhu, Lucía, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fosf4jk1rks0760l0uln80or57